RG9MTD1 Antibody (A-8): sc-515289

RG9MTD1 Antibody (A-8) is a mouse monoclonal IgM kappa antibody that detects RG9MTD1 protein of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). RG9MTD1 (A-8) antibody is available as a non-conjugated format. RG9MTD1 protein belongs to the RNA methyltransferase family, playing a vital role in transferring methyl groups to RNA molecules and influencing various cellular processes. RG9MTD1 functions in RNA modification, which regulates gene expression, cell growth, and signaling pathways. Such modification affects RNA stability and translation, impacting cellular function and potentially contributing to tumorigenesis. RG9MTD1 protein, along with RG9MTD2 and RG9MTD3, participates in methylation events that may lead to carcinogenesis, making RG9MTD1 significant in cancer research. While RG9MTD1 and RG9MTD2 exist as single isoforms, RG9MTD3 is expressed in three isoforms through alternative splicing, potentially diversifying functional roles in cellular processes.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

RG9MTD1 Antibody (A-8) References:

1. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.  |  Scanlan, MJ., et al. 1999. Int J Cancer. 83: 456-64. PMID: 10508479
2. [Screening of the genes of hepatitis B virus PreS2 interacting proteins].  |  Lu, YY., et al. 2003. Zhonghua Gan Zang Bing Za Zhi. 11: 8-10. PMID: 12546731
3. The consensus coding sequences of human breast and colorectal cancers.  |  Sjöblom, T., et al. 2006. Science. 314: 268-74. PMID: 16959974
4. Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient.  |  Benayoun, L., et al. 2007. Mol Genet Metab. 90: 453-7. PMID: 17275380

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-RG9MTD1 Antibody (A-8) has 0 citations in a variety of scientific publications.

Primary antibodies like Anti-RG9MTD1 Antibody (A-8) for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

RG9MTD1 Antibody (A-8) Specifications

Alternate Product Name: RG9MTD1

Product Clone Name: A-8

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgM kappa light chain

Amino Acids: 331-355

Epitope Target: RG9MTD1

Epitope Species: human

Product Reactivity/Detection: RG9MTD1

Species Reactivity/Detection: mouse, rat, human

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: WB, IP, IF, ELISA

Vialing Information: Each vial contains 200 µg IgM kappa light chain in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 0 citations in various scientific publications

Available Conjugates/Forms for RG9MTD1 Antibody (A-8): P: Blocking Peptide